Elafin - 0.1 mg
- Cat.Number : AS-61641
 - Manufacturer Ref. :
 - 
                                Availability : 
        In stock
 
This is a fragment of the elafin (elastase-specific inhibitor), an antiproteinase and antimicrobial (gram-positive and gram-negative respiratory pathogens) molecule that is expressed at epithelial sites. Elafin is a potent inhibitor of HNE and proteinase 3 produced in the skin, and in the airways , which is up-regulated in response to early inflammatory cytokines such as TNF and IL-1. Elafin, along with SLPI, also shares characteristics with antimicrobial defensin-like molecules in being a low molecular weight cationic peptide with the ability to eliminate pulmonary pathogens.
Specifications
| Chemistry | |
| Sequence one letter code | 
                                    
  | 
                        
|---|---|
| Sequence three letter code | 
                                    
  | 
                        
| Molecular Mass/ Weight | 
                                    
  | 
                        
| Modification | |
| Conjugation | 
                                    
  | 
                        
| Quantity & Purity | |
| Purity | 
                                     | 
                        
| Storage & stability | |
| Form | 
                                    
  | 
                        
| Storage Conditions | 
                                    
  | 
                        
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage | 
                                    
  | 
                        
| Source | |
| Source / Species | 
                                    
  | 
                        
| Codes | |
| Code Nacres | 
                                    
  | 
                        
Downloads
You may also be interested in the following product(s)
            
            
            Citations
Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function.
Arterioscler Thromb Vasc Biol . 2012 Nov 29 ; 33(2) 275 | DOI : 10.1161/ATVBAHA.112.300474
- CJ. Kuckleburg
 - PJ. Newman